81 related articles for article (PubMed ID: 34100088)
1. Corrigendum to: Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients.
Takeyasu Y; Yoshida T; Motoi N; Teishikata T; Tanaka M; Matsumoto Y; Shinno Y; Okuma Y; Goto Y; Horinouchi H; Kakishima H; Tsuchida T; Yamamoto N; Ohe Y; Yatabe Y
Jpn J Clin Oncol; 2021 Jul; 51(7):1183. PubMed ID: 34100088
[No Abstract] [Full Text] [Related]
2. Feasibility of next-generation sequencing (Oncomine™ DX Target Test) for the screening of oncogenic mutations in advanced non-small-cell lung cancer patients.
Takeyasu Y; Yoshida T; Motoi N; Teishikata T; Tanaka M; Matsumoto Y; Shinno Y; Okuma Y; Goto Y; Horinouchi H; Kakishima H; Tsuchida T; Yamamoto N; Ohe Y; Yatabe Y
Jpn J Clin Oncol; 2021 Jul; 51(7):1114-1122. PubMed ID: 33881137
[TBL] [Abstract][Full Text] [Related]
3. Multiple Biomarker Testing Tissue Consumption and Completion Rates With Single-gene Tests and Investigational Use of Oncomine Dx Target Test for Advanced Non-Small-cell Lung Cancer: A Single-center Analysis.
Yu TM; Morrison C; Gold EJ; Tradonsky A; Layton AJ
Clin Lung Cancer; 2019 Jan; 20(1):20-29.e8. PubMed ID: 30243889
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing for tumor mutation quantification using liquid biopsies.
Provencio M; Pérez-Barrios C; Barquin M; Calvo V; Franco F; Sánchez E; Sánchez R; Marsden D; Cristóbal Sánchez J; Martin Acosta P; Laza-Briviesca R; Cruz-Bermúdez A; Romero A
Clin Chem Lab Med; 2020 Jan; 58(2):306-313. PubMed ID: 31469650
[TBL] [Abstract][Full Text] [Related]
5. The long tail of molecular alterations in non-small cell lung cancer: a single-institution experience of next-generation sequencing in clinical molecular diagnostics.
Fumagalli C; Vacirca D; Rappa A; Passaro A; Guarize J; Rafaniello Raviele P; de Marinis F; Spaggiari L; Casadio C; Viale G; Barberis M; Guerini-Rocco E
J Clin Pathol; 2018 Sep; 71(9):767-773. PubMed ID: 29535211
[TBL] [Abstract][Full Text] [Related]
6. The evolving landscape of biomarker testing for non-small cell lung cancer in Europe.
Kerr KM; Bibeau F; Thunnissen E; Botling J; Ryška A; Wolf J; Öhrling K; Burdon P; Malapelle U; Büttner R
Lung Cancer; 2021 Apr; 154():161-175. PubMed ID: 33690091
[TBL] [Abstract][Full Text] [Related]
7. Validation of a next generation sequencing panel for detection of hotspot cancer mutations in a clinical laboratory.
Shahsiah R; DeKoning J; Samie S; Latifzadeh SZ; Kashi ZM
Pathol Res Pract; 2017 Feb; 213(2):98-105. PubMed ID: 28049581
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity of next-generation sequencing assays detecting oncogenic fusions in plasma cell-free DNA.
Supplee JG; Milan MSD; Lim LP; Potts KT; Sholl LM; Oxnard GR; Paweletz CP
Lung Cancer; 2019 Aug; 134():96-99. PubMed ID: 31320002
[TBL] [Abstract][Full Text] [Related]
9. A pilot study of next generation sequencing-liquid biopsy on cell-free DNA as a novel non-invasive diagnostic tool for Klippel-Trenaunay syndrome.
Palmieri M; Pinto AM; di Blasio L; Currò A; Monica V; Sarno LD; Doddato G; Baldassarri M; Frullanti E; Giliberti A; Mussolin B; Fallerini C; Molinaro F; Vaghi M; Renieri A; Primo L
Vascular; 2021 Feb; 29(1):85-91. PubMed ID: 32588787
[TBL] [Abstract][Full Text] [Related]
10. Transformation to small cell lung cancer as a mechanism of resistance to immunotherapy in non-small cell lung cancer.
Bar J; Ofek E; Barshack I; Gottfried T; Zadok O; Kamer I; Urban D; Perelman M; Onn A
Lung Cancer; 2019 Dec; 138():109-115. PubMed ID: 31683093
[TBL] [Abstract][Full Text] [Related]
11. Amplicon-based next-generation sequencing of plasma cell-free DNA for detection of driver and resistance mutations in advanced non-small cell lung cancer.
Guibert N; Hu Y; Feeney N; Kuang Y; Plagnol V; Jones G; Howarth K; Beeler JF; Paweletz CP; Oxnard GR
Ann Oncol; 2018 Apr; 29(4):1049-1055. PubMed ID: 29325035
[TBL] [Abstract][Full Text] [Related]
12. Molecular Screening of Small Biopsy Samples Using Next-Generation Sequencing in Korean Patients with Advanced Non-small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01).
Ku BM; Heo MH; Kim JH; Cho BC; Cho EK; Min YJ; Lee KH; Sun JM; Lee SH; Ahn JS; Park K; Kim TJ; Lee HY; Kim H; Lee KJ; Ahn MJ
J Pathol Transl Med; 2018 May; 52(3):148-156. PubMed ID: 29575851
[TBL] [Abstract][Full Text] [Related]
13. Tumor volume determines the feasibility of cell-free DNA sequencing for mutation detection in non-small cell lung cancer.
Ohira T; Sakai K; Matsubayashi J; Kajiwara N; Kakihana M; Hagiwara M; Hibi M; Yoshida K; Maeda J; Ohtani K; Nagao T; Nishio K; Ikeda N
Cancer Sci; 2016 Nov; 107(11):1660-1666. PubMed ID: 27575703
[TBL] [Abstract][Full Text] [Related]
14. Robust assessment of tumor mutational burden in cytological specimens from lung cancer patients.
Alborelli I; Bratic Hench I; Chijioke O; Prince SS; Bubendorf L; Leuenberger LP; Tolnay M; Leonards K; Quagliata L; Jermann P; Matter MS
Lung Cancer; 2020 Nov; 149():84-89. PubMed ID: 32980613
[TBL] [Abstract][Full Text] [Related]
15. Mutational landscape and characteristics of ERBB2 in non-small cell lung cancer.
Wei XW; Gao X; Zhang XC; Yang JJ; Chen ZH; Wu YL; Zhou Q
Thorac Cancer; 2020 Jun; 11(6):1512-1521. PubMed ID: 32291971
[TBL] [Abstract][Full Text] [Related]
16. Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
Zheng R; Shen Q; Mardekian S; Solomides C; Wang ZX; Evans NR
J Thorac Cardiovasc Surg; 2020 Aug; 160(2):e71-e79. PubMed ID: 32007245
[TBL] [Abstract][Full Text] [Related]
17. Comparison of EML4-ALK fusion gene positive rate in different detection methods and samples of non-small cell lung cancer.
Lu S; Lu C; Xiao Y; Zhu W; He Q; Xie B; Zhou J; Tao Y; Liu S; Xiao D
J Cancer; 2020; 11(6):1525-1531. PubMed ID: 32047559
[No Abstract] [Full Text] [Related]
18. BRCA1/2 somatic mutation detection in formalin-fixed paraffin embedded tissue by next-generation sequencing in Korean ovarian cancer patients.
Lee A; Kang J; Lee H; Lee YS; Choi YJ; Lee KH; Nistala GJ; Scafe CR; Choi J; Yoo J; Han M D E; Kim Y; Kim M
Pathol Res Pract; 2019 Nov; 215(11):152595. PubMed ID: 31570282
[TBL] [Abstract][Full Text] [Related]
19. A novel
Chaudhary S; Krishna BM; Mishra SK
Oncol Lett; 2017 Aug; 14(2):1247-1264. PubMed ID: 28789340
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the clinical application of detecting EGFR, KRAS, PIK3CA and BRAF mutations in patients with non-small cell lung cancer using next-generation sequencing.
Xu X; Yang Y; Li H; Chen Z; Jiang G; Fei K
Scand J Clin Lab Invest; 2016 Sep; 76(5):386-92. PubMed ID: 27215271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]